Literature DB >> 24057890

Interaction of different antidepressants with acute and chronic methadone in mice, and possible clinical implications.

Shaul Schreiber1, Yonatan Barak, Avner Hostovsky, Renana Baratz-Goldstein, Ina Volis, Vardit Rubovitch, Chaim G Pick.   

Abstract

We studied the interaction of a single dose of different antidepressant medications with a single (acute) dose or implanted mini-pump (chronic) methadone administration in mice, using the hotplate assay. For the acute experiment, subthreshold doses of six antidepressant drugs were administered separately with a single dose of methadone. The addition of a subthreshold dose of desipramine or clomipramine to methadone produced significant augmentation of the methadone effect with each drug (p < 0.05). Fluvoxamine given at a fixed subthreshold dose induced a synergistic effect only with a low methadone dose. Escitalopram, reboxetine and venlafaxine given separately, each at a fixed subthreshold dose, induced no interaction. Possible clinical implications of these findings are that while escitalopram, reboxetine and venlafaxine do not affect methadone's antinociception in mice and are safe to be given together with methadone when indicated, fluvoxamine, clomipramine and desipramine considerably augment methadone-induced effects and should be avoided in this population due to the risk of inducing opiate overdose. For the chromic experiment, when a subthreshold dose of either escitalopram, desipramine or clomipramine was injected to mice following 2 weeks of methadone administration with the mini-pump, none of the antidepressant drugs strengthened methadone's analgesic effect. Further studies are needed before possible clinical implications can be drawn.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24057890     DOI: 10.1007/s12031-013-0115-4

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  50 in total

1.  Fluoxetine for blepharospasm: interaction of serotonin and dopamine.

Authors:  S Schreiber; C G Pick
Journal:  J Nerv Ment Dis       Date:  1995-11       Impact factor: 2.254

2.  Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.

Authors:  S M Stahl
Journal:  J Clin Psychiatry       Date:  1998-12       Impact factor: 4.384

3.  Paroxetine for secondary stuttering: further interaction of serotonin and dopamine.

Authors:  S Schreiber; C G Pick
Journal:  J Nerv Ment Dis       Date:  1997-07       Impact factor: 2.254

4.  The antinociceptive effect of fluvoxamine.

Authors:  S Schreiber; M M Backer; J Yanai; C G Pick
Journal:  Eur Neuropsychopharmacol       Date:  1996-11       Impact factor: 4.600

Review 5.  Combination drug therapy for chronic pain: a call for more clinical studies.

Authors:  Jianren Mao; Michael S Gold; Miroslav Misha Backonja
Journal:  J Pain       Date:  2010-09-17       Impact factor: 5.820

6.  Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.

Authors:  Massimiliano Aragona; Lara Bancheri; Donatella Perinelli; Lorenzo Tarsitani; Alessia Pizzimenti; Antonella Conte; Maurizio Inghilleri
Journal:  Eur J Pain       Date:  2005-02       Impact factor: 3.931

7.  Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.

Authors:  E A Muth; J T Haskins; J A Moyer; G E Husbands; S T Nielsen; E B Sigg
Journal:  Biochem Pharmacol       Date:  1986-12-15       Impact factor: 5.858

Review 8.  Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis.

Authors:  Edward V Nunes; Frances R Levin
Journal:  JAMA       Date:  2004-04-21       Impact factor: 56.272

9.  The antinociceptive properties of reboxetine in acute pain.

Authors:  Shaul Schreiber; Ruthi Frishtick; Ina Volis; Vardit Rubovitch; Chaim G Pick; Ronit Weizman
Journal:  Eur Neuropsychopharmacol       Date:  2009-07-05       Impact factor: 4.600

Review 10.  Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews.

Authors:  Kurt Kroenke; Erin E Krebs; Matthew J Bair
Journal:  Gen Hosp Psychiatry       Date:  2009-03-04       Impact factor: 3.238

View more
  1 in total

1.  Magnesium Salt, a Simple Strategy to Improve Methadone Analgesia in Chronic Pain: An Isobolographic Preclinical Study in Neuropathic Mice.

Authors:  Valeria González; Teresa Pelissier; Victoria Cazanga; Alejandro Hernández; Luis Constandil
Journal:  Front Pharmacol       Date:  2020-05-08       Impact factor: 5.810

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.